Features

The Recent History of “Contagious Shooting” (1982-2006) and more recent events in Ferguson, Missouri

A version of this post first appeared on Stephen T. Casper’s blog, The Neuro Times.

In the decade since the “Decade of the Brain,” the neurosciences have acquired a spectacular cache in the humanities and social sciences. One need look no further than the work of Nikolas Rose and Joelle M. Abi-Rached, scholars who argue in their striking volume …

Features

Autism, sociality, and human nature

There are, I believe, a few reasons to suppose that autism is a particularly fascinating area to be studying at the moment.  What are those reasons?  Firstly, prevalence rates of autism have soared in recent decades, from 1:2,500 in 1978 to around 1:100 today: a staggering 25-fold increase.  Secondly, and simultaneously, the nature of those receiving a diagnosis of autism …

Web Roundups

Web Roundup: Accidents and myths

What role do accidents play in determining our lives and histories? What, even, is an accident? How does something come to be thought of as “accidental”? This month’s Web Roundup features stories on accidents and their aftermath.

Starting us off, Slate has an excellent article about Phineas Gage, the most famous patient of neurosurgery ever. For those who don’t …

Announcements

Plasticity and Pathology: A Workshop – UC Berkeley, Rhetoric Department – April 11 & 12, 2014

Plasticity and Pathology: History and Theory of Neural Subjects

Organized by David Bates and Nima Bassiri

Friday, April 11

1.00 pm Welcome from Workshop Organizers (David Bates and Nima Bassiri)

1.15 – 3.15 pm Session One

Laura Salisbury (English, Exeter)
TBA [On narrative and neural subjects in Luria]

Nima Bassiri (ACLS Fellow, Literature and Neuroscience, Duke)
“Epileptic Insanity and Personal …

Features

The broad clinical gaze in paediatric deep brain stimulation

Deep brain stimulation (DBS) involves using a pacemaker-like device to deliver constant, carefully targeted electrical stimulation to areas within the brain. It was first approved in the late 1990s as a therapy for managing the symptoms of Parkinson’s disease. The initial success of DBS led clinicians and device manufacturers to explore other possible applications, and in 2003 it was approved …